Conagen's Fermentation Technology To Support DARPA's ReSource Sustainability Program
08 déc. 2021 04h34 HE | Conagen
Bedford, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Massachusetts-based biotech Conagen announced its participation in a collaboration supporting the ReSource program funded by a U.S. Department of...
Olives and Wine: Conagen Makes Accessible Antioxidant Hydroxytyrosol by Fermentation
10 sept. 2021 15h25 HE | Conagen
Bedford, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Leveraging its robust phenolics platform, Conagen announced the expansion of the health ingredient portfolio of its commercial partner Blue...
Conagen Expands Natural Preservation by Fermentation
24 août 2021 06h00 HE | Conagen
Bedford, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- As the "clean label" trend thrives in many consumer product categories, Massachusetts-based biotech Conagen announced the launch of a natural...
Conagen’s Novel Solution to Making Natural Capsaicin by Fermentation Accessible
22 avr. 2021 12h23 HE | Conagen
Bedford, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Scalable, sustainable capsaicin ingredients for its use in food, consumer and industrial products have now become more accessible. Conagen...
Conagen Begins Scale Up of Natural Sustainable Musk Macrocyclic Lactone Fragrance Materials
11 janv. 2021 05h00 HE | Conagen
Bedford, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Conagen announced today its breakthrough development in the commercial production of natural and sustainable macrocyclic musk lactones from natural...
Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin
29 sept. 2020 04h00 HE | Conagen
Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human...
Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas
19 août 2020 06h00 HE | Conagen
Bedford, Mass., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Conagen, a rapidly-growing Boston-based biotechnology firm, has established a novel and proprietary process for the scalable production of a non-GMO...
Conagen Receives a Strategic Investment from Sumitomo Chemical
31 mars 2020 15h51 HE | Conagen
Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) -- Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment...
Infant Formula Evolves and Advances in Nutrition
24 mars 2020 21h55 HE | Conagen
Bedford, Mass., March 24, 2020 (GLOBE NEWSWIRE) -- Conagen announced today the discovery and development of a sustainable proprietary lactoferrin protein that mirrors the nutritional properties of...